To meet the broad needs of cytokine detection based on ELISA method and solve its limitations such as long operation time and batch-to-batch difference, ACROBiosystems have specifically developed a series of ClinMax™ cytokine detection kits, aiming to provide a more reliable analytical reagent for drug discovery, quality control, preclinical study and clinical trials.
ClinMax™, for better transition from early research to clinical phases.
Image credit: ACROBiosystems
ACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents to support the development of target therapeutics, vaccines, and diagnostics. The company employs an application-oriented development strategy, with a particular focus on product design, quality control and solution-based support. Our products and services enable anyone in the field of drug development to have a more intuitive and streamlined process.
ACROBiosystems' catalog includes a comprehensive list of disease-associated biomarkers and drug targets from humans to other common species. All of our products are produced with high quality and batch-to-batch consistency to satisfy the rigorous standards of pharmaceutical research and development.
ACROBiosystems continue to grow and adapt to bring more value to our clients by providing more technical resources and custom services, promoting training and communication opportunities, initiating collaborations in the bio-industry community, and facilitating transactions in the dynamic global and each niche market.